Company: BLLN
Filing Date: 2025-09-17
Form Type: DRS/A
Source: 0001193125-25-206347
Chunk: 394

Company: BillionToOne, Inc.
Filing Date: 2025-09-17
Form: DRS/A
Chunk 394
---
 change in fair value of the term loan; interest expense under the Oberland Capital arrangement was $2.0 million for the six months ended June 30, 2025. Total debt outstanding as of December 31, 2024 and June 30, 2025 was $51.5 million and $52.1 million, respectively, and included within long-term debt on the Company’s balance sheets. Future principal payments of the Company’s long-term debt as of December 31, 2024 and June 30, 2025 $50.0 million, is due during the year ending December 31, 2031. The term loan advances are secured by a lien on the Company’s assets. Redeemable Convertible Preferred Stock Warrants The Company has issued Comerica Bank a warrant to purchase 9,660 Series A-6redeemable convertible preferred shares at an exercise price of $2.59 per share in connection with a former loan and security agreement entered into in March 2020. The warrants are exercisable until March 15, 2030. The warrants are classified as liabilities on the Company’s balance sheet. Common Stock Warrants In connection with the 2021 LSA, the Company issued to Western Alliance Bank (“WAB”) warrants to purchase shares of the Company’s common stock at an exercise price of $2.80 per share. The number of underlying shares of the warrants was initially 53,571 and was increased to 80,357 upon the funding of the loans in January 2022. The warrants will expire if unexercised on October 12, 2031. Upon the occurrence of an acquisition of the Company, if the acquiror shall not have assumed the warrants, WAB shall have the right to put the warrants back to the Company for cash equal to the greater of (x) $450,000 or (y) the value of the aggregate consideration payable to WAB had WAB exercised the warrants immediately prior to exercise such put right. F-56

BILLIONTOONE, INC. Notes to Unaudited Interim Financial Statements In connection with the 2022 LSA Amendment, the Company issued up to 41,209 warrants for common stock at an exercise price of $10.92 per share to WAB. 30,907 warrants were exercisable upon execution of the agreement; the remaining warrants become exercisable as the Company makes additional draws on the 2022 LSA Amendment. As of December 31